The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular outcomes shows they have significant benefits in people with and without diabetes.
source https://www.sciencedaily.com/releases/2024/11/241125195050.htm
Google will end dark web reports that alerted users to leaked data
-
Google began offering “dark web reports” a while back, but the company has
just announced the feature will be going away very soon. In an email to
users ...
11 hours ago
Welcome to the 'The Fact Factory' friends. Its an interesting Hot Spot which brings to you amazing and little known facts from all over the world. So, sit back, take a tour around the world and enjoy the trivia.
No comments:
Post a Comment